Nuclera

Nuclera, a health tech company based in Cambridge, has successfully closed an £8.9 million Series C extension funding round.

Summary of transaction details:

• Value: £8.9 million
• Sector: Health tech
• Advisor: Not disclosed
• Key Entities: Nuclera (Target), Elevage Medical Technologies, Jonathan Milner, British Business Bank, GK Goh (Investors)
• Location: Cambridge, UK

Note: This funding round represents a significant boost for Nuclera's ongoing development in multiplex protein screening, reflecting strong investor interest in innovative health technologies and their market potential.